Evidence map›Paper›PMID 39677927›Full record

ArticleJBMR plus2025

Leor Needleman, Nicolette Chun, Sathvika Sitaraman, Marilyn Tan, Deborah E Sellmeyer, Electron Kebebew, Justin P Annes

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JBMR plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leor NeedlemanDepartment of Medicine, Division of Endocrinology, Stanford University, Stanford, CA 94305, United States.ORCID https://orcid.org/0009-0006-5637-5591
Nicolette ChunDepartment of Genetics, Stanford University, Stanford CA 94305, United States.
Sathvika SitaramanDepartment of Medicine, Division of Endocrinology, Stanford University, Stanford, CA 94305, United States.
Marilyn TanDepartment of Medicine, Division of Endocrinology, Stanford University, Stanford, CA 94305, United States.
Deborah E SellmeyerDepartment of Medicine, Division of Endocrinology, Stanford University, Stanford, CA 94305, United States.ORCID https://orcid.org/0000-0003-4571-1386
Electron KebebewStanford Cancer Institute, Stanford University, Stanford, CA 94305, United States.
Justin P AnnesDepartment of Medicine, Division of Endocrinology, Stanford University, Stanford, CA 94305, United States.

Funding

Diabetes, Endocrinology and Metabolism Training GrantT32DK007217 · NIDDK · STANFORD UNIVERSITY · PI Justin Pierce Annes, David Matthew Maahs · 1987 to 2026
$7.2M
The Role of Adenosine Kinase in Controlling Beta-Cell RegenerationR01DK101530 · NIDDK · STANFORD UNIVERSITY · PI ANNES, JUSTIN PIERCE · 2015 to 2024
$3.8M
Development of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug StrategyR01DK119955 · NIDDK · STANFORD UNIVERSITY · PI ANNES, JUSTIN PIERCE · 2019 to 2023
$2.1M
Developing A Platform Technology For β-Cell-Targeted Drug DeliveryU01DK136965 · NIDDK · STANFORD UNIVERSITY · PI Justin Pierce Annes · 2023 to 2026
$2.0M
NIDDK NIH HHS R01 DK101530NIDDK NIH HHS R01 DK119955NIDDK NIH HHS T32 DK007217NIDDK NIH HHS U01 DK136965
6 · The paper itself

Abstract

Germline and somatic pathogenic variants in the

Indexed as

Cdc73, aberrant splicingHPT-JTprimary hyperparathyroidismRNA sequencing

Identifiers

PMID39677927
PMCPMC11646312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.